1. Home
  2. TVA vs CYRX Comparison

TVA vs CYRX Comparison

Compare TVA & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVA
  • CYRX
  • Stock Information
  • Founded
  • TVA 2024
  • CYRX 1999
  • Country
  • TVA United States
  • CYRX United States
  • Employees
  • TVA N/A
  • CYRX N/A
  • Industry
  • TVA
  • CYRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TVA
  • CYRX Health Care
  • Exchange
  • TVA Nasdaq
  • CYRX Nasdaq
  • Market Cap
  • TVA 303.4M
  • CYRX 328.9M
  • IPO Year
  • TVA 2025
  • CYRX N/A
  • Fundamental
  • Price
  • TVA $10.09
  • CYRX $7.79
  • Analyst Decision
  • TVA
  • CYRX Strong Buy
  • Analyst Count
  • TVA 0
  • CYRX 8
  • Target Price
  • TVA N/A
  • CYRX $10.75
  • AVG Volume (30 Days)
  • TVA 5.0K
  • CYRX 598.5K
  • Earning Date
  • TVA 01-01-0001
  • CYRX 08-05-2025
  • Dividend Yield
  • TVA N/A
  • CYRX N/A
  • EPS Growth
  • TVA N/A
  • CYRX N/A
  • EPS
  • TVA N/A
  • CYRX N/A
  • Revenue
  • TVA N/A
  • CYRX $232,134,000.00
  • Revenue This Year
  • TVA N/A
  • CYRX N/A
  • Revenue Next Year
  • TVA N/A
  • CYRX $9.63
  • P/E Ratio
  • TVA N/A
  • CYRX N/A
  • Revenue Growth
  • TVA N/A
  • CYRX 11.75
  • 52 Week Low
  • TVA $9.99
  • CYRX $4.58
  • 52 Week High
  • TVA $10.50
  • CYRX $9.78
  • Technical
  • Relative Strength Index (RSI)
  • TVA N/A
  • CYRX 60.41
  • Support Level
  • TVA N/A
  • CYRX $6.16
  • Resistance Level
  • TVA N/A
  • CYRX $6.98
  • Average True Range (ATR)
  • TVA 0.00
  • CYRX 0.42
  • MACD
  • TVA 0.00
  • CYRX 0.05
  • Stochastic Oscillator
  • TVA 0.00
  • CYRX 88.98

About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share

Texas Ventures Acquisition III Corp is a blank check company.

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Share on Social Networks: